Evidence map›Paper›PMID 30662652›Full record

ArticleAmerican journal of translational research2018

Upregulation of miR-335 ameliorates myocardial ischemia reperfusion injury via targeting hypoxia inducible factor 1-alpha subunit inhibitor.

Nan Wu, Xiaowen Zhang, Shuyan Du, Dong Chen, Ruichao Che

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Inhibition of Long Noncoding RNAMolecular and cellular biology · 2021
    Article
  8. Inhibition of lncRNAMolecular medicine reports · 2021
    Article
  9. Review
  10. Article
  11. Article
  12. The Future of Direct Cardiac Reprogramming: AnyInternational journal of molecular sciences · 2020
    Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Nan WuThe Central Laboratory of The First Affiliated Hospital of China Medical University Shenyang, China.
Xiaowen ZhangMedical Research Center, Shengjing Hospital of China Medical University Shenyang, China.
Shuyan DuThe Central Laboratory of The First Affiliated Hospital of China Medical University Shenyang, China.
Dong ChenThe Central Laboratory of The First Affiliated Hospital of China Medical University Shenyang, China.
Ruichao CheThe Central Laboratory of The First Affiliated Hospital of China Medical University Shenyang, China.
First Hospital of China Medical University · CNChina Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNA-335 (miR-335) is implicated in several pathophysiological processes, including tumorigenesis, lipid metabolism and ischemic stroke; however, whether miR-335 plays a role in modulating myocardial ischemia reperfusion injury (MIRI) is still unknown. This study is aimed to explore the role and mechanism of miR-335 in the pathophysiological process of MIRI. Specifically, miR-335 mimics or a chemically modified agomiR-335 were transfected or injected into H9c2 cells and Wistar rats to upregulate miR-335 expression

Indexed as

apoptosishypoxia inducible factor 1-alphaMicroRNAmitochondrial permeability transition poremyocardial ischemia reperfusion injury

Identifiers

PMID30662652
PMCPMC6325516
OpenAlexW2990159366

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.